BRIEF-Abbott Receives FDA Approval For New Cardiomems Hf System Capabilities That Help Patients Engage In The Care Of Their Heart Condition
Reuters2026/10/05 13:12Abbott Laboratories ABT.N: ABBOTT RECEIVES FDA APPROVAL FOR NEW CARDIOMEMS HF SYSTEM CAPABILITIES THAT HELP PATIENTS ENGAGE IN THE CARE OF THEIR HEART CONDITION ABBOTT RECEIVES FDA APPROVAL FOR NEW CARDIOMEMS HF SYSTEM CAPABILITIES THAT HELP PATIENTS ENGAGE IN THE CARE OF THEIR HEART CONDITION ABBOTT - CARDIOGUIDE HF APP AND DYNAMIC TREATMENT PLAN TO BE AVAILABLE LATER THIS YEAR Source text: ID:nPn32xVP2a Further company coverage: ABT.N
Abbott Laboratories ABT.N:
ABBOTT RECEIVES FDA APPROVAL FOR NEW CARDIOMEMS HF SYSTEM CAPABILITIES THAT HELP PATIENTS ENGAGE IN THE CARE OF THEIR HEART CONDITION
ABBOTT RECEIVES FDA APPROVAL FOR NEW CARDIOMEMS HF SYSTEM CAPABILITIES THAT HELP PATIENTS ENGAGE IN THE CARE OF THEIR HEART CONDITION
ABBOTT - CARDIOGUIDE HF APP AND DYNAMIC TREATMENT PLAN TO BE AVAILABLE LATER THIS YEAR
Source text: ID:nPn32xVP2a
Further company coverage: ABT.N
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Boss Energy Downgraded to Equal-weight from Overweight by Morgan Stanley
Crypto PACs report $2.7M spending blitz on House races as midterms loom
US accounting overhaul could make stablecoins more attractive to corporations: Tempo
Bitcoin miners face widening AI financing costs as lenders scrutinize deals
Crypto prices
More
